Creative Medical Technology Holdings, Inc.

NASDAQ:CELZHealthcare · Biotechnology

Mkt Cap$5.11M

Float6.56M

Shares O/S7.59M

Inst Own5.1%

SI1.3%

Dilution

CLOSED · Nov 3+8.02%$0.6735

CLOSED · Nov 3

Prev close$0.6235+8.02%Close$0.6735-2.00%AH close$0.6600

VOL117K$ Vol$76KRVOL1.09x

AH$0.6600-2.00%vs close

Mkt Cap$5.11M

Float6.56M

O/S7.59M

VOL117K sh

$ Vol$76K

RVOL1.09×

Inst Own5.1%

SI1.3%

Dilution

NASDAQ:CELZClosed$0.6735+8.02%

MCap$5.11M

Float6.56M

O/S7.59M

VOL117K sh$ Vol$76KRVOL1.09×

SI1.3%

Inst Own5.1%

Dilution

Historical Data

Date	Open	High	Low	Close	Volume
Nov 3, 2026	0.6450	0.6736	0.6300	0.6735	116,537
Nov 2, 2026	0.6502	0.6737	0.6006	0.6235	224,681
Oct 30, 2026	0.7190	0.7190	0.6541	0.6550	87,324
Oct 29, 2026	0.7225	0.7376	0.6750	0.6784	62,652
Oct 28, 2026	0.6925	0.7249	0.6717	0.7200	90,695
Oct 27, 2026	0.7348	0.7383	0.6810	0.6902	142,128
Oct 26, 2026	0.7651	0.7655	0.7100	0.7120	44,897
Oct 23, 2026	0.7651	0.7679	0.7311	0.7400	24,515
Oct 22, 2026	0.7535	0.7798	0.7401	0.7740	54,094
Oct 21, 2026	0.7500	0.7646	0.7300	0.7424	50,761
Oct 20, 2026	0.7020	0.7800	0.6800	0.7547	413,370
Oct 19, 2026	0.7474	0.7474	0.7222	0.7236	95,676
Oct 16, 2026	0.8390	0.8493	0.7340	0.7410	172,958
Oct 15, 2026	0.7799	0.8206	0.7628	0.8178	63,118
Oct 14, 2026	0.8000	0.8000	0.7571	0.7723	167,465
Oct 13, 2026	0.8300	0.8500	0.8100	0.8199	56,876
Oct 12, 2026	0.8300	0.8685	0.8220	0.8410	90,209
Oct 9, 2026	0.8602	0.8800	0.8200	0.8385	149,369
Oct 8, 2026	0.8800	0.8930	0.8601	0.8604	41,281
Oct 7, 2026	0.9100	0.9100	0.8801	0.8890	52,220

Analyst Coverage

ConsensusBuy

Price Target

Not available

Ratings Distribution

BUY

HOLD

SELL

TOTAL1

Insider Trades

Insider	Title	Type	Shares	Value	Date
Warbington Timothy	President & CEO	Grant/Award	1.00M	--	Sep 24, 2026
Finger Michael H.	Director	Sale	750	$4.3K	Feb 19, 2025
Finger Michael H.	Director	Sale	750	$3.8K	Feb 18, 2025

Shareholders

5.1%

Institutional

(17)

0.0%

Insiderⓘ

(1)

13.7%

5%+ Owners

(1)

81.2%

Unattributed (incl. retail)ⓘ

Institutional5.1%

Insider0.0%

5%+ Beneficial13.7%

Unattributed (incl. retail)81.2%

Top Shareholders

Name	Shares	%	Source
Timothy Warbington · joint filing· may incl. warrants· filed Oct 2026	1.0M	13.7%	13D
Armistice Capital, LLC · also on 13F· may incl. warrants· filed Aug 2025	135.5K	1.8%	13G
Hudson Bay Capital Management LP	135.2K	1.8%	13F
Anson Funds Management LP	105.5K	1.4%	13F
ARMISTICE CAPITAL, LLC	42.0K	0.6%	13F
XTX Topco Ltd	26.6K	0.3%	13F
GEODE CAPITAL MANAGEMENT, LLC	25.8K	0.3%	13F
VANGUARD CAPITAL MANAGEMENT LLC	20.4K	0.3%	13F
StoneX Group Inc.	15.3K	0.2%	13F
VANGUARD FIDUCIARY TRUST CO	5.5K	0.1%	13F

Sources: 13F, Form 4, 13D/13GO/S: 7.6M · as of 24 Sep 2026 · SEC filings

Insiders & Institutional Holders

Insiders

Warbington TimothyPresident & CEO
Finger Michael H.Director

Top institutional holders

About

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments.

The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Key Metrics

Market Cap$5.11M

Enterprise Value--

P/E Ratio--

Est. Net Cash/Share--

Institutional Ownership5.11%

based on 7.59M shares outstanding

SectorHealthcare

IndustryBiotechnology

ExchangeNASDAQ

Country

IPO DateNov 6, 2015

Shares Outstanding7.59M

Float6.56M

52-Week Range

$0.6006$6.25

$0.6735(1st percentile)

Volume

Average Daily Volume106.68K

116.54K today vs 106.68K avg(+9%)

30d Avg

106.68K

60d Avg

672.54K

90d Avg

6.17M

Earnings

Dividend History

No dividend history available

Compliance Status